Implications of subclinical tuberculosis for vaccine trial design and global effect. - Churchyard GJ; Houben RMGJ; Fielding K; Fiore-Gartland AL; Esmail H; Grant AD; Rangaka MX; Behr M; Garcia-Basteiro AL; Wong EB; Hatherill M; Mave V; et al. (The Lancet. Microbe, 2024)